NCT02283775 - SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2015

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions

Plasma Cell Myeloma

Interventions

DRUG

Isatuximab SAR650984

Pharmaceutical form:solution for infusion Route of administration: intravenous

DRUG

Pomalidomide

Pharmaceutical form:capsules Route of administration: oral

DRUG

Dexamethasone

Pharmaceutical form:tablets or solution for infusion Route of administration: oral or intravenous

Trial Locations (13)

Investigational Site Number 840104, Boston

Investigational Site Number 840010, Chapel Hill

Investigational Site Number 840003, Charlotte

Investigational Site Number 840016, Charleston

Investigational Site Number 840014, Canton

Investigational Site Number 840017, Milwaukee

Investigational Site Number 840011, Decatur

Investigational Site Number 840001, Scottsdale

Investigational Site Number 840006, Duarte

Investigational Site Number 840005, Seattle

Investigational Site Number 840018, New Haven

Investigational Site Number 840004, Boston

Investigational Site Number 840015, Salt Lake City